A powerful new study from Europe’s leading supercomputing and biomedical research centre is reshaping how scientists understand the ageing immune system.

Published in prestigious journal Nature Aging, the research shows, for the first time with molecular precision, that the immune system ages in markedly different ways in women and men.

These differences, long suspected but poorly explained, are now mapped down to individual cells and genes.

The findings matter. They help explain why women are more prone to autoimmune diseases, particularly later in life, and why older men face a higher risk of certain blood cancers.

More broadly, the work challenges the long-standing assumption that immune ageing follows a single, universal path. Instead, it reveals two distinct biological trajectories shaped by sex, age, and cellular behaviour.

For decades, population-level statistics have hinted at deep immunological contrasts. Men tend to suffer more severe infections and higher rates of many cancers. Women, by contrast, generally mount stronger immune responses.

Vaccines often work better in women. Yet this heightened reactivity comes at a cost. Around 80 per cent of autoimmune diseases develop in women, conditions in which the immune system mistakenly attacks the body’s own tissues.

“The results are striking. Women show more pronounced immune changes as they age. There is a clear expansion of inflammatory immune cells over time”

Until now, these differences were visible only in broad clinical outcomes. The underlying cellular mechanisms remained elusive. Traditional studies typically averaged immune signals across millions of cells, smoothing away subtle but important shifts that unfold over time. Sex differences were often ignored or underpowered. Women, in particular, were frequently underrepresented.

That gap has now been closed.

By analysing blood samples from nearly 1,000 adults spanning the full range of adult life, researchers applied single-cell RNA sequencing to more than one million individual immune cells. Each cell was examined in isolation. The activity of roughly 20,000 genes was measured per cell, producing one of the most detailed portraits of human immune ageing ever assembled.

Handling data at this scale required exceptional computational muscle. Advanced technology and algorithms, developed specifically for this task, were run on one of Europe’s most powerful supercomputers. Without such infrastructure, the study would not have been feasible. The payoff was unprecedented resolution.

The results are striking. Women show more pronounced immune changes as they age. There is a clear expansion of inflammatory immune cells over time. These cells, while essential for fighting infections, can drive chronic inflammation when present in excess. This slow-burning inflammatory state is increasingly recognised as a hallmark of ageing and a contributor to many age-related diseases.

In women, this inflammatory shift is stronger and more widespread. The study links it to specific immune cell populations and gene expression patterns that become more active with age. These molecular signatures help explain why autoimmune diseases are far more common in women, and why many inflammatory conditions worsen after menopause.

Hormonal changes likely play a role, although the study focused on cellular and genetic dynamics rather than endocrine mechanisms. Still, the timing aligns with clinical observations.

After menopause, rates of conditions such as rheumatoid arthritis and other autoimmune disorders often increase or become more severe. The new data provide a biological framework to understand why.

Men, on the other hand, follow a different path. Their immune ageing appears less extensive overall, at least in terms of inflammatory expansion. However, the study uncovered another, more insidious change. Certain blood cell populations in older men showed genetic alterations associated with pre-leukaemic states. These changes do not mean cancer is inevitable, but they raise the risk.

This finding offers a plausible explanation for a well-documented trend. Blood cancers, including some forms of leukaemia, occur more frequently in older men than in women. The newly identified cellular patterns suggest that immune ageing in men may tilt towards genomic instability in specific blood cells rather than widespread inflammation.

Together, these sex-specific trajectories paint a more nuanced picture of immunosenescence, the gradual decline and remodelling of immune function with age. Ageing, it turns out, is not a single biological script. It is edited by sex at multiple levels, from gene regulation to cell population dynamics.

The technical approach was central to the breakthrough. Single-cell RNA sequencing allows scientists to capture the voice of each cell, rather than listening to a noisy crowd. Subtle shifts that would disappear in averaged data become visible. Rare but important cell types can be tracked across decades of life. Patterns emerge slowly, then clearly.

Equally important was the balanced study design. Men and women were represented in roughly equal numbers across age groups. This may sound obvious, but it remains uncommon. Many previous studies relied heavily on male samples or failed to analyse sex as a biological variable. As a result, key questions about female biology were left unanswered.

This research set out to correct that imbalance. It combined inclusive sampling with cutting-edge technology and high-performance computing. The outcome is a dataset that does not just confirm known differences, but explains them.

The implications extend well beyond immunology. The immune system interacts with every organ in the body. It shapes responses to infection, cancer, injury, and even neurodegenerative disease. Differences in immune ageing can therefore influence health trajectories across multiple systems.

From a clinical perspective, the findings strengthen the case for sex-specific approaches to healthy ageing and disease prevention. Precision medicine often focuses on genetics, lifestyle, or environment. Biological sex, despite its profound influence, is still too often treated as a secondary factor.

This study argues otherwise. It identifies sex-specific ageing cells and molecular biomarkers that could, in time, guide tailored screening strategies. For women, monitoring inflammatory immune shifts might help identify those at higher risk of autoimmune disease or chronic inflammatory conditions. For men, tracking pre-leukaemic cellular changes could improve early detection of blood cancers.

The research also raises questions about interventions. Could anti-inflammatory strategies be timed or targeted differently in women? Might surveillance of blood cell genetics in older men reduce cancer risk through earlier action? These are not immediate clinical applications, but the groundwork is now laid.

Importantly, the study avoids framing one immune system as better than the other. Stronger immune responses, often seen in women, bring advantages and risks. Weaker or less reactive responses, more typical in men, carry their own trade-offs. Evolution has shaped both strategies. Age modifies them in distinct ways.

The study’s authors emphasise that treating ageing as a homogeneous process hides crucial biological variation. One-size-fits-all models risk missing early warning signs or misjudging risk in half the population. By contrast, a sex-aware framework offers sharper tools and fairer healthcare.

While the research focused on blood, its relevance extends further. Immune cells circulate and infiltrate tissues throughout the body. Changes observed in the bloodstream may reflect, or even drive, alterations in organs such as the brain, heart, and joints. Future studies may explore how these immune ageing patterns relate to conditions like dementia, cardiovascular disease, or osteoporosis.

There are, of course, limits. The study does not fully disentangle the roles of hormones, lifestyle, or environmental exposures. Nor does it claim that all women or all men age in the same way. Individual variation remains substantial. Sex is a powerful factor, not a destiny.

Even so, the message is clear. Biological sex shapes immune ageing in deep, measurable ways. Ignoring it is no longer scientifically defensible.

By revealing the cellular and genetic choreography behind immune ageing, this research marks a turning point in health research and the approach to treatment. It transforms long-standing observations into actionable biological insight. It also sends a broader signal to the medical community.

As societies grapple with longer lifespans and rising chronic disease, such knowledge becomes a foundation for healthier ageing, designed with both women and men in mind.